Steven Burner
Family Medicine · Oklahoma City, OKNPI 1538199450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $805 and has fallen 87.0% since, to $105 in 2023.
Across 192 payments — averaging $13.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$550
- Pfizer$426
- Astellas Pharma US Inc$380
- GSK$127
- Abbott$92
- Amarin Pharma, Inc.$92
- plus $870 from 24 others
What the payments were for
- Food & beverage$2,532100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $550 |
| Pfizer | 34 | $426 |
| Astellas Pharma US Inc | 26 | $380 |
| GSK | 9 | $127 |
| Abbott | 5 | $92 |
| Amarin Pharma, Inc. | 6 | $92 |
| Amgen(2 entities) | 6 | $91 |
| Novo Nordisk | 5 | $70 |
| Novartis | 5 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| AstraZeneca | 4 | $63 |
| Bayer | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Johnson & Johnson | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 3 | $43 |
| Boehringer Ingelheim | 3 | $42 |
| Genentech USA, Inc. | 3 | $40 |
| Antares Pharma, Inc. | 2 | $29 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Almatica Pharma LLC | 1 | $11 |
How this compares
$2,537 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Alexander FrankOklahoma City$3.1M
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
- Jonathon KnoxOklahoma City$20K
- Steven SacketOklahoma City$17K
- Stanley CorleyOklahoma City$16K
- Teddy WebbOklahoma City$15K
- Judy MagnussonOklahoma City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.